Anna Wilkins

Institute of Cancer Research — United Kingdom

Medicine · Health Sciences

21h-index2.3kcitations79works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(22), Prostate Cancer Diagnosis and Treatment(20), Cancer Immunotherapy and Biomarkers(16), Bladder and Urothelial Cancer Treatments(10), Advanced Radiotherapy Techniques(8)

Publications79 total

POPS: a randomised trial of image-guided prostate bed radiotherapy using the rectal obturator ProSpare® (NCT02978014): Acute toxicity and dosimetry
European Urology Open Science·2025Open Access
Beyond tumour mutational burden: Determinants of response to combination radiation/immunotherapy in Muscle-Invasive Bladder Cancer (MIBC)
European Urology Open Science·2025Open Access
Bladder function studies as predictors of acute toxicity from stereotactic radiotherapy (SBRT) to the prostate - Can we improve patient selection and outcomes?
European Urology Open Science·2025Open Access
Rapid expansion of podoplanin-positive fibroblasts following radiation limits the anti-tumour CD8+ T-cell response to radiotherapy
2025Open Access
Targeting Cancer-associated Fibroblasts (CAFs) to Optimize Radiation Responses
The Cancer Journal·2025· 2 cited
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference
OncoImmunology·2025· 3 citedOpen Access
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics·2025· 4 citedOpen Access
Abstract SY36-02: Interrogating how the dialogue between immune cells and fibroblasts impacts radiotherapy outcomes
Cancer Research·2025
O02 A randomised phase II trial investigating whether radiotherapy can improve response to atezolizumab in patients with metastatic urothelial carcinoma not initially responding to immunotherapy: RE-ARM results
European Urology Open Science·2024Open Access
<scp><i>TP53</i></scp> mutations in urothelial carcinoma: not all one and the same<sup>†</sup>
The Journal of Pathology·2024· 2 citedOpen Access
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer
Nature Cancer·2024· 23 citedOpen Access
Targeting CAFs
Elsevier eBooks·2024
WITHDRAWN: Targeting CAFs
Elsevier eBooks·2024
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation
Journal of Clinical Investigation·2023· 38 citedOpen Access
The sex gap in bladder cancer survival — a missing link in bladder cancer care?
Nature Reviews Urology·2023· 21 citedOpen Access
Application of digital pathology‐based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response
The Journal of Pathology·2023· 23 citedOpen Access
P41 Improving health screening for psychiatric patients admitted to an adult inpatient mental health unit
SSM Annual Scientific Meeting·2023
International Society of Urological Pathology ( <scp>ISUP)</scp> Gleason Grade Groups stratify outcomes in the <scp>CHHiP</scp> Phase 3 prostate radiotherapy trial
British Journal of Urology·2023· 2 citedOpen Access
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition
International Journal of Radiation Oncology*Biology*Physics·2023· 1 citedOpen Access
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 <sup>th</sup> annual ImmunoRad conference
OncoImmunology·2023· 12 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

David P. Dearnaley(17), Emma Hall(17), Alan Melcher(13), Kevin J. Harrington(13), Isabel Syndikus(10), Clare Griffin(8), Olivia Naismith(8), Navita Somaiah(8), S. Gulliford(7), Chris Parker(6), John Staffurth(6), Clare Cruickshank(6), Alison Tree(6), Emmanuel C. Patin(5), Douglas Brand(5), Julia Murray(5), Martin McLaughlin(4), Magnus T. Dillon(4), Erik Sahai(4), Vincent Khoo(4)